A Phase Ib/II, Open-label, Multicenter Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma
Phase of Trial: Phase I/II
Latest Information Update: 25 Oct 2016
At a glance
- Drugs Binimetinib (Primary) ; Sotrastaurin (Primary)
- Indications Uveal melanoma
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Sponsors Novartis
- 21 Jul 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 02 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2014 Planned number of patients changed from 125 to 157 as reported by ClinicalTrials.gov.